Thilo Schroeder
SlowingNamed in filings at Nextech Invest
- Board seats filed
- 8
all filings on record
Named in filings at Nextech Invest
all filings on record
last 24 months
from a verified or cited source
| Stipple Bio | Not yet classified | March 2026 | None on file |
| Alterome Therapeutics | Biotech & pharma | December 2021 | Vida Ventures |
| Silverback Therapeutics | Biotech & pharma | March 2020 | U.S Venture Partners |
| Circle Pharma | Biotech & pharma | March 2020 | The Column Group |
| Revolution Medicines | Biotech & pharma | March 2018 | Curie Bio, Third Rock Ventures |
| Ideaya Biosciences | Not yet classified | January 2018 | None on file |
| IMAGINAB | Biotech & pharma | March 2016 | Third Rock Ventures |
| Blueprint Medicines | Biotech & pharma | January 2014 | Curie Bio, Third Rock Ventures |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The category is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Categories of companies where filings name Thilo Schroeder on the board, based on 6 filed seats with a verified or cited source.
2 more filed seats not yet classified, left out of the shares above.